RAYMOND W COHEN Insider Trading Transactions
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for RAYMOND W COHEN.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of RAYMOND W COHEN. RAYMOND W COHEN is Director in BIOLIFE SOLUTIONS INC ($BLFS) and CEO in CARDIAC SCIENCE INC ($DFIB) and Chairman and CEO in CARDIAC SCIENCE INC ($DFIB) and Director in SPECTRUM PHARMACEUTICALS INC ($SPPI) and Chief Executive Officer in Axonics Modulation Technologies, Inc. ($AXNX).
Latest Insider Trading Transactions of RAYMOND W COHEN
| 1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
|---|---|---|---|---|---|---|---|
| No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Sentiment: All, AXNX, BLFS, DFIB, SPPI
Page: 1
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Jun 10 2021 | AXNX | Axonics, Inc. | COHEN RAYMOND W | Chief Executive Off ... | Sell | S | 60.00 | 33,333 | 1,999,980 | 284,607 | 317.9 K to 284.6 K (-10.48 %) |
| May 12 2021 | AXNX | Axonics, Inc. | COHEN RAYMOND W | Chief Executive Off ... | Sell | S | 54.81 | 2,770 | 151,824 | 350,773 | 353.5 K to 350.8 K (-0.78 %) |
| May 12 2021 | AXNX | Axonics, Inc. | COHEN RAYMOND W | Chief Executive Off ... | Sell | S | 54.13 | 17,954 | 971,798 | 353,543 | 371.5 K to 353.5 K (-4.83 %) |
| May 12 2021 | AXNX | Axonics, Inc. | COHEN RAYMOND W | Chief Executive Off ... | Sell | S | 52.98 | 13,109 | 694,536 | 371,497 | 384.6 K to 371.5 K (-3.41 %) |
| Feb 02 2021 | AXNX | Axonics Modulation ... | COHEN RAYMOND W | Chief Executive Off ... | Option Exercise | M | 0.00 | 16,667 | 0 | 0 | |
| Feb 02 2021 | AXNX | Axonics Modulation ... | COHEN RAYMOND W | Chief Executive Off ... | Option Exercise | A | 0.00 | 42,500 | 0 | 42,500 | |
| Feb 02 2021 | AXNX | Axonics Modulation ... | COHEN RAYMOND W | Chief Executive Off ... | Option Exercise | A | 0.00 | 20,000 | 0 | 20,000 | |
| Feb 02 2021 | AXNX | Axonics Modulation ... | COHEN RAYMOND W | Chief Executive Off ... | Sell | S | 52.12 | 952 | 49,616 | 456,096 | 457 K to 456.1 K (-0.21 %) |
| Feb 02 2021 | AXNX | Axonics Modulation ... | COHEN RAYMOND W | Chief Executive Off ... | Sell | S | 51.36 | 12,675 | 651,045 | 457,048 | 469.7 K to 457 K (-2.70 %) |
| Feb 02 2021 | AXNX | Axonics Modulation ... | COHEN RAYMOND W | Chief Executive Off ... | Buy | M | 0.00 | 33,334 | 0 | 469,723 | 436.4 K to 469.7 K (+7.64 %) |
| Feb 02 2021 | AXNX | Axonics Modulation ... | COHEN RAYMOND W | Chief Executive Off ... | Grant | A | 0.00 | 20,000 | 0 | 436,389 | 416.4 K to 436.4 K (+4.80 %) |
| Jan 27 2021 | AXNX | Axonics Modulation ... | COHEN RAYMOND W | Chief Executive Off ... | Option Exercise | M | 0.00 | 27,173 | 0 | 0 | |
| Jan 27 2021 | AXNX | Axonics Modulation ... | COHEN RAYMOND W | Chief Executive Off ... | Sell | S | 53.58 | 7,842 | 420,148 | 416,389 | 424.2 K to 416.4 K (-1.85 %) |
| Jan 27 2021 | AXNX | Axonics Modulation ... | COHEN RAYMOND W | Chief Executive Off ... | Buy | M | 0.00 | 27,173 | 0 | 424,231 | 397.1 K to 424.2 K (+6.84 %) |
| Nov 16 2020 | BLFS | BIOLIFE SOLUTIONS ... | COHEN RAYMOND W | Director | Sell | S | 32.45 | 5,625 | 182,531 | 22,763 | 28.4 K to 22.8 K (-19.81 %) |
| Nov 16 2020 | BLFS | BIOLIFE SOLUTIONS ... | COHEN RAYMOND W | Director | Sell | S | 32.45 | 5,625 | 182,531 | 22,763 | 28.4 K to 22.8 K (-19.81 %) |
| Aug 11 2020 | AXNX | Axonics Modulation ... | COHEN RAYMOND W | Chief Executive Off ... | Sell | S | 42.78 | 11,033 | 471,948 | 397,058 | 408.1 K to 397.1 K (-2.70 %) |
| Aug 11 2020 | AXNX | Axonics Modulation ... | COHEN RAYMOND W | Chief Executive Off ... | Sell | S | 42.05 | 8,808 | 370,406 | 408,091 | 416.9 K to 408.1 K (-2.11 %) |
| Aug 11 2020 | AXNX | Axonics Modulation ... | COHEN RAYMOND W | Chief Executive Off ... | Sell | S | 40.95 | 5,159 | 211,282 | 416,899 | 422.1 K to 416.9 K (-1.22 %) |
| Aug 11 2020 | AXNX | Axonics Modulation ... | COHEN RAYMOND W | Chief Executive Off ... | Sell | S | 42.75 | 3,367 | 143,924 | 422,058 | 425.4 K to 422.1 K (-0.79 %) |
| Aug 11 2020 | AXNX | Axonics Modulation ... | COHEN RAYMOND W | Chief Executive Off ... | Sell | S | 41.82 | 16,633 | 695,659 | 425,425 | 442.1 K to 425.4 K (-3.76 %) |
| Jul 17 2020 | AXNX | Axonics Modulation ... | COHEN RAYMOND W | Chief Executive Off ... | Sell | S | 39.65 | 25,000 | 991,268 | 442,058 | 467.1 K to 442.1 K (-5.35 %) |
| Jul 17 2020 | AXNX | Axonics Modulation ... | COHEN RAYMOND W | Chief Executive Off ... | Sell | S | 39.94 | 900 | 35,943 | 467,058 | 468 K to 467.1 K (-0.19 %) |
| Jul 17 2020 | AXNX | Axonics Modulation ... | COHEN RAYMOND W | Chief Executive Off ... | Sell | S | 39.61 | 15,472 | 612,804 | 467,958 | 483.4 K to 468 K (-3.20 %) |
| Jul 17 2020 | AXNX | Axonics Modulation ... | COHEN RAYMOND W | Chief Executive Off ... | Sell | S | 38.55 | 8,628 | 332,579 | 483,430 | 492.1 K to 483.4 K (-1.75 %) |
| Jul 15 2020 | AXNX | Axonics Modulation ... | COHEN RAYMOND W | Chief Executive Off ... | Sell | S | 36.49 | 25,000 | 912,273 | 492,058 | 517.1 K to 492.1 K (-4.84 %) |
| Jul 15 2020 | AXNX | Axonics Modulation ... | COHEN RAYMOND W | Chief Executive Off ... | Sell | S | 41.10 | 200 | 8,220 | 517,058 | 517.3 K to 517.1 K (-0.04 %) |
| Jul 15 2020 | AXNX | Axonics Modulation ... | COHEN RAYMOND W | Chief Executive Off ... | Sell | S | 40.34 | 24,800 | 1,000,541 | 517,258 | 542.1 K to 517.3 K (-4.58 %) |
| Jul 15 2020 | AXNX | Axonics Modulation ... | COHEN RAYMOND W | Chief Executive Off ... | Sell | S | 36.49 | 25,000 | 912,273 | 492,058 | 517.1 K to 492.1 K (-4.84 %) |
| Jul 15 2020 | AXNX | Axonics Modulation ... | COHEN RAYMOND W | Chief Executive Off ... | Sell | S | 41.10 | 200 | 8,220 | 517,058 | 517.3 K to 517.1 K (-0.04 %) |
| Jul 15 2020 | AXNX | Axonics Modulation ... | COHEN RAYMOND W | Chief Executive Off ... | Sell | S | 40.34 | 24,800 | 1,000,541 | 517,258 | 542.1 K to 517.3 K (-4.58 %) |
| Mar 18 2020 | AXNX | Axonics Modulation ... | COHEN RAYMOND W | Chief Executive Off ... | Option Exercise | M | 1.63 | 41,224 | 67,195 | 106,776 | |
| Mar 18 2020 | AXNX | Axonics Modulation ... | COHEN RAYMOND W | Chief Executive Off ... | Sell | S | 21.48 | 6,955 | 149,390 | 542,058 | 549 K to 542.1 K (-1.27 %) |
| Mar 18 2020 | AXNX | Axonics Modulation ... | COHEN RAYMOND W | Chief Executive Off ... | Sell | S | 20.87 | 34,269 | 715,249 | 549,013 | 583.3 K to 549 K (-5.88 %) |
| Mar 18 2020 | AXNX | Axonics Modulation ... | COHEN RAYMOND W | Chief Executive Off ... | Buy | M | 1.63 | 41,224 | 67,195 | 583,282 | 542.1 K to 583.3 K (+7.61 %) |
| Feb 18 2020 | AXNX | Axonics Modulation ... | COHEN RAYMOND W | Chief Executive Off ... | Option Exercise | M | 1.63 | 10,000 | 16,300 | 148,000 | |
| Feb 18 2020 | AXNX | Axonics Modulation ... | COHEN RAYMOND W | Chief Executive Off ... | Sell | S | 33.21 | 10,000 | 332,065 | 542,058 | 552.1 K to 542.1 K (-1.81 %) |
| Feb 18 2020 | AXNX | Axonics Modulation ... | COHEN RAYMOND W | Chief Executive Off ... | Buy | M | 1.63 | 10,000 | 16,300 | 552,058 | 542.1 K to 552.1 K (+1.84 %) |
| Feb 03 2020 | AXNX | Axonics Modulation ... | COHEN RAYMOND W | Chief Executive Off ... | Option Exercise | M | 0.00 | 16,667 | 0 | 0 | |
| Feb 03 2020 | AXNX | Axonics Modulation ... | COHEN RAYMOND W | Chief Executive Off ... | Option Exercise | M | 0.00 | 16,667 | 0 | 0 | |
| Feb 03 2020 | AXNX | Axonics Modulation ... | COHEN RAYMOND W | Chief Executive Off ... | Buy | M | 0.00 | 16,667 | 0 | 625,058 | 608.4 K to 625.1 K (+2.74 %) |
| Feb 03 2020 | AXNX | Axonics Modulation ... | COHEN RAYMOND W | Chief Executive Off ... | Buy | M | 0.00 | 16,667 | 0 | 625,058 | 608.4 K to 625.1 K (+2.74 %) |
| Jan 16 2020 | AXNX | Axonics Modulation ... | COHEN RAYMOND W | Chief Executive Off ... | Option Exercise | M | 1.63 | 10,000 | 16,300 | 158,000 | |
| Jan 16 2020 | AXNX | Axonics Modulation ... | COHEN RAYMOND W | Chief Executive Off ... | Sell | S | 31.98 | 10,000 | 319,800 | 608,391 | 618.4 K to 608.4 K (-1.62 %) |
| Jan 16 2020 | AXNX | Axonics Modulation ... | COHEN RAYMOND W | Chief Executive Off ... | Buy | M | 1.63 | 10,000 | 16,300 | 618,391 | 608.4 K to 618.4 K (+1.64 %) |
| Dec 16 2019 | AXNX | Axonics Modulation ... | COHEN RAYMOND W | Chief Executive Off ... | Option Exercise | A | 25.82 | 78,125 | 2,017,188 | 78,125 | |
| Dec 16 2019 | AXNX | Axonics Modulation ... | COHEN RAYMOND W | Chief Executive Off ... | Option Exercise | A | 0.00 | 27,173 | 0 | 27,173 | |
| Dec 16 2019 | AXNX | Axonics Modulation ... | COHEN RAYMOND W | Chief Executive Off ... | Option Exercise | A | 0.00 | 27,173 | 0 | 27,173 | |
| Nov 21 2019 | AXNX | Axonics Modulation ... | COHEN RAYMOND W | Chief Executive Off ... | Sell | S | 20.74 | 75,000 | 1,555,125 | 608,391 | 683.4 K to 608.4 K (-10.97 %) |
| Aug 19 2019 | BLFS | BIOLIFE SOLUTIONS ... | COHEN RAYMOND W | Director | Option Exercise | M | 1.12 | 5,357 | 6,000 | 0 | |
| Aug 19 2019 | BLFS | BIOLIFE SOLUTIONS ... | COHEN RAYMOND W | Director | Sell | S | 17.98 | 5,357 | 96,319 | 23,388 | 28.7 K to 23.4 K (-18.64 %) |
| Aug 19 2019 | BLFS | BIOLIFE SOLUTIONS ... | COHEN RAYMOND W | Director | Buy | M | 1.12 | 5,357 | 6,000 | 28,745 | 23.4 K to 28.7 K (+22.90 %) |
| Aug 06 2019 | AXNX | Axonics Modulation ... | COHEN RAYMOND W | Chief Executive Off ... | Buy | P | 30.41 | 3,500 | 106,439 | 683,391 | 679.9 K to 683.4 K (+0.51 %) |
| Jul 17 2019 | BLFS | BIOLIFE SOLUTIONS ... | COHEN RAYMOND W | Director | Option Exercise | M | 1.12 | 5,357 | 6,000 | 0 | |
| Jul 17 2019 | BLFS | BIOLIFE SOLUTIONS ... | COHEN RAYMOND W | Director | Option Exercise | M | 1.12 | 5,357 | 6,000 | 0 | |
| Jul 17 2019 | BLFS | BIOLIFE SOLUTIONS ... | COHEN RAYMOND W | Director | Sell | S | 16.57 | 5,357 | 88,765 | 23,388 | 28.7 K to 23.4 K (-18.64 %) |
| Jul 17 2019 | BLFS | BIOLIFE SOLUTIONS ... | COHEN RAYMOND W | Director | Sell | S | 16.57 | 5,357 | 88,765 | 23,388 | 28.7 K to 23.4 K (-18.64 %) |
| Jul 17 2019 | BLFS | BIOLIFE SOLUTIONS ... | COHEN RAYMOND W | Director | Buy | M | 1.12 | 5,357 | 6,000 | 28,745 | 23.4 K to 28.7 K (+22.90 %) |
| Jul 17 2019 | BLFS | BIOLIFE SOLUTIONS ... | COHEN RAYMOND W | Director | Buy | M | 1.12 | 5,357 | 6,000 | 28,745 | 23.4 K to 28.7 K (+22.90 %) |
| Jun 21 2019 | SPPI | SPECTRUM PHARMACEU ... | COHEN RAYMOND W | Director | Option Exercise | A | 8.44 | 20,000 | 168,800 | 20,000 | |
| Jun 21 2019 | SPPI | SPECTRUM PHARMACEU ... | COHEN RAYMOND W | Director | Grant | A | 0.00 | 10,000 | 0 | 53,850 | 43.9 K to 53.9 K (+22.81 %) |
| Jun 21 2019 | SPPI | SPECTRUM PHARMACEU ... | COHEN RAYMOND W | Director | Option Exercise | A | 8.44 | 20,000 | 168,800 | 20,000 | |
| Jun 21 2019 | SPPI | SPECTRUM PHARMACEU ... | COHEN RAYMOND W | Director | Grant | A | 0.00 | 10,000 | 0 | 53,850 | 43.9 K to 53.9 K (+22.81 %) |
| Jun 19 2019 | BLFS | BIOLIFE SOLUTIONS ... | COHEN RAYMOND W | Director | Option Exercise | M | 1.40 | 5,357 | 7,500 | 0 | |
| Jun 19 2019 | BLFS | BIOLIFE SOLUTIONS ... | COHEN RAYMOND W | Director | Sell | S | 17.48 | 5,357 | 93,640 | 23,388 | 28.7 K to 23.4 K (-18.64 %) |
| Jun 19 2019 | BLFS | BIOLIFE SOLUTIONS ... | COHEN RAYMOND W | Director | Buy | M | 1.40 | 5,357 | 7,500 | 28,745 | 23.4 K to 28.7 K (+22.90 %) |
| May 17 2019 | BLFS | BIOLIFE SOLUTIONS ... | COHEN RAYMOND W | Director | Option Exercise | M | 1.90 | 10,000 | 19,000 | 0 | |
| May 17 2019 | BLFS | BIOLIFE SOLUTIONS ... | COHEN RAYMOND W | Director | Sell | S | 17.99 | 15,000 | 269,850 | 23,388 | 38.4 K to 23.4 K (-39.07 %) |
| May 17 2019 | BLFS | BIOLIFE SOLUTIONS ... | COHEN RAYMOND W | Director | Sell | S | 16.98 | 10,000 | 169,800 | 38,388 | 48.4 K to 38.4 K (-20.67 %) |
| May 17 2019 | BLFS | BIOLIFE SOLUTIONS ... | COHEN RAYMOND W | Director | Buy | M | 1.90 | 10,000 | 19,000 | 48,388 | 38.4 K to 48.4 K (+26.05 %) |
| Apr 19 2019 | BLFS | BIOLIFE SOLUTIONS ... | COHEN RAYMOND W | Director | Option Exercise | M | 2.06 | 15,000 | 30,900 | 0 | |
| Apr 19 2019 | BLFS | BIOLIFE SOLUTIONS ... | COHEN RAYMOND W | Director | Sell | S | 17.03 | 15,000 | 255,450 | 38,388 | 53.4 K to 38.4 K (-28.10 %) |
| Apr 19 2019 | BLFS | BIOLIFE SOLUTIONS ... | COHEN RAYMOND W | Director | Buy | M | 2.06 | 15,000 | 30,900 | 53,388 | 38.4 K to 53.4 K (+39.07 %) |
| Apr 19 2019 | BLFS | BIOLIFE SOLUTIONS ... | COHEN RAYMOND W | Director | Option Exercise | M | 2.06 | 15,000 | 30,900 | 0 | |
| Apr 19 2019 | BLFS | BIOLIFE SOLUTIONS ... | COHEN RAYMOND W | Director | Sell | S | 17.03 | 15,000 | 255,450 | 38,388 | 53.4 K to 38.4 K (-28.10 %) |
| Apr 19 2019 | BLFS | BIOLIFE SOLUTIONS ... | COHEN RAYMOND W | Director | Buy | M | 2.06 | 15,000 | 30,900 | 53,388 | 38.4 K to 53.4 K (+39.07 %) |
| Mar 18 2019 | SPPI | SPECTRUM PHARMACEU ... | COHEN RAYMOND W | Director | Grant | A | 9.59 | 5,000 | 47,950 | 43,850 | 38.9 K to 43.9 K (+12.87 %) |
| Feb 04 2019 | AXNX | Axonics Modulation ... | COHEN RAYMOND W | Chief Executive Off ... | Option Exercise | A | 0.00 | 16,667 | 0 | 16,667 | |
| Feb 04 2019 | AXNX | Axonics Modulation ... | COHEN RAYMOND W | Chief Executive Off ... | Option Exercise | A | 0.00 | 16,667 | 0 | 16,667 | |
| Feb 04 2019 | AXNX | Axonics Modulation ... | COHEN RAYMOND W | Chief Executive Off ... | Option Exercise | A | 14.19 | 222,222 | 3,153,330 | 222,222 | |
| Dec 26 2018 | BLFS | BIOLIFE SOLUTIONS ... | COHEN RAYMOND W | Director | Option Exercise | M | 1.26 | 5,357 | 6,755 | 0 | |
| Dec 26 2018 | BLFS | BIOLIFE SOLUTIONS ... | COHEN RAYMOND W | Director | Buy | M | 1.26 | 5,357 | 6,755 | 38,388 | 33 K to 38.4 K (+16.22 %) |
| Nov 02 2018 | AXNX | Axonics Modulation ... | COHEN RAYMOND W | Chief Executive Off ... | Option Exercise | C | 0.00 | 7,300 | 0 | 0 | |
| Nov 02 2018 | AXNX | Axonics Modulation ... | COHEN RAYMOND W | Chief Executive Off ... | Buy | C | 0.00 | 8,760 | 0 | 688,651 | 679.9 K to 688.7 K (+1.29 %) |
| Aug 22 2018 | BLFS | BIOLIFE SOLUTIONS ... | COHEN RAYMOND W | Director | Sell | S | 23.68 | 10,000 | 236,800 | 33,031 | 43 K to 33 K (-23.24 %) |
| Aug 14 2018 | BLFS | BIOLIFE SOLUTIONS ... | COHEN RAYMOND W | Director | Sell | S | 19.70 | 10,000 | 197,000 | 43,031 | 53 K to 43 K (-18.86 %) |
| Jun 19 2018 | SPPI | SPECTRUM PHARMACEU ... | COHEN RAYMOND W | Director | Option Exercise | A | 19.95 | 20,000 | 399,000 | 20,000 | |
| Jun 19 2018 | SPPI | SPECTRUM PHARMACEU ... | COHEN RAYMOND W | Director | Grant | A | 0.00 | 10,000 | 0 | 38,850 | 28.9 K to 38.9 K (+34.66 %) |
| Jun 01 2018 | BLFS | BIOLIFE SOLUTIONS ... | COHEN RAYMOND W | Director | Sell | S | 10.15 | 10,000 | 101,500 | 53,031 | 63 K to 53 K (-15.87 %) |
| May 15 2018 | SPPI | SPECTRUM PHARMACEU ... | COHEN RAYMOND W | Director | Sell | S | 18.32 | 9,275 | 169,918 | 28,850 | 38.1 K to 28.9 K (-24.33 %) |
| Jan 03 2018 | BLFS | BIOLIFE SOLUTIONS ... | COHEN RAYMOND W | Director | Grant | A | 0.00 | 3,125 | 0 | 65,656 | 62.5 K to 65.7 K (+5.00 %) |
| Jan 03 2018 | BLFS | BIOLIFE SOLUTIONS ... | COHEN RAYMOND W | Director | Grant | A | 0.00 | 15,000 | 0 | 62,531 | 47.5 K to 62.5 K (+31.56 %) |
| Oct 03 2017 | BLFS | BIOLIFE SOLUTIONS ... | COHEN RAYMOND W | Director | Grant | A | 0.00 | 3,325 | 0 | 58,068 | 54.7 K to 58.1 K (+6.07 %) |
| Jul 07 2017 | BLFS | BIOLIFE SOLUTIONS ... | COHEN RAYMOND W | Director | Grant | A | 0.00 | 7,845 | 0 | 54,743 | 46.9 K to 54.7 K (+16.73 %) |
| Jun 29 2017 | SPPI | SPECTRUM PHARMACEU ... | COHEN RAYMOND W | Director | Payment of Exercise | F | 7.54 | 625 | 4,713 | 43,125 | 43.8 K to 43.1 K (-1.43 %) |
| Jun 15 2017 | SPPI | SPECTRUM PHARMACEU ... | COHEN RAYMOND W | Director | Option Exercise | A | 6.48 | 20,000 | 129,600 | 20,000 | |
| Jun 15 2017 | SPPI | SPECTRUM PHARMACEU ... | COHEN RAYMOND W | Director | Option Exercise | A | 6.48 | 20,000 | 129,600 | 20,000 | |
| Jun 15 2017 | SPPI | SPECTRUM PHARMACEU ... | COHEN RAYMOND W | Director | Grant | A | 0.00 | 10,000 | 0 | 43,750 | 33.8 K to 43.8 K (+29.63 %) |
| Jun 15 2017 | SPPI | SPECTRUM PHARMACEU ... | COHEN RAYMOND W | Director | Grant | A | 0.00 | 10,000 | 0 | 43,750 | 33.8 K to 43.8 K (+29.63 %) |
| Jun 15 2017 | SPPI | SPECTRUM PHARMACEU ... | COHEN RAYMOND W | Director | Payment of Exercise | F | 6.48 | 2,500 | 16,200 | 33,750 | 36.3 K to 33.8 K (-6.90 %) |
| Jun 15 2017 | SPPI | SPECTRUM PHARMACEU ... | COHEN RAYMOND W | Director | Payment of Exercise | F | 6.48 | 2,500 | 16,200 | 33,750 | 36.3 K to 33.8 K (-6.90 %) |
| Apr 06 2017 | BLFS | BIOLIFE SOLUTIONS ... | COHEN RAYMOND W | Director | Grant | A | 0.00 | 8,929 | 0 | 46,898 | 38 K to 46.9 K (+23.52 %) |
| Feb 09 2017 | BLFS | BIOLIFE SOLUTIONS ... | COHEN RAYMOND W | Director | Option Exercise | M | 1.12 | 17,857 | 20,000 | 0 | |
| Feb 09 2017 | BLFS | BIOLIFE SOLUTIONS ... | COHEN RAYMOND W | Director | Buy | M | 1.12 | 17,857 | 20,000 | 37,969 | 20.1 K to 38 K (+88.79 %) |
| Jan 18 2017 | BLFS | BIOLIFE SOLUTIONS ... | COHEN RAYMOND W | Director | Grant | A | 0.00 | 11,646 | 0 | 20,112 | 8.5 K to 20.1 K (+137.56 %) |
| Jun 29 2016 | SPPI | SPECTRUM PHARMACEU ... | COHEN RAYMOND W | Director | Option Exercise | A | 6.33 | 20,000 | 126,600 | 20,000 | |
| Jun 29 2016 | SPPI | SPECTRUM PHARMACEU ... | COHEN RAYMOND W | Director | Grant | A | 0.00 | 10,000 | 0 | 36,250 | 26.3 K to 36.3 K (+38.10 %) |
| Jun 29 2016 | SPPI | SPECTRUM PHARMACEU ... | COHEN RAYMOND W | Director | Payment of Exercise | F | 6.33 | 2,500 | 15,825 | 26,250 | 28.8 K to 26.3 K (-8.70 %) |
| Jun 29 2016 | SPPI | SPECTRUM PHARMACEU ... | COHEN RAYMOND W | Director | Payment of Exercise | F | 6.47 | 625 | 4,044 | 28,750 | 29.4 K to 28.8 K (-2.13 %) |
| Mar 17 2016 | BLFS | BIOLIFE SOLUTIONS ... | COHEN RAYMOND W | Director | Option Exercise | A | 1.90 | 10,000 | 19,000 | 10,000 | |
| Jul 08 2015 | SPPI | SPECTRUM PHARMACEU ... | COHEN RAYMOND W | Director | Payment of Exercise | F | 6.96 | 625 | 4,350 | 29,375 | 30 K to 29.4 K (-2.08 %) |
| Jul 01 2015 | SPPI | SPECTRUM PHARMACEU ... | COHEN RAYMOND W | Director | Option Exercise | A | 6.96 | 20,000 | 139,200 | 20,000 | |
| Jul 01 2015 | SPPI | SPECTRUM PHARMACEU ... | COHEN RAYMOND W | Director | Grant | A | 0.00 | 10,000 | 0 | 30,000 | 20 K to 30 K (+50.00 %) |
| May 06 2015 | BLFS | BIOLIFE SOLUTIONS ... | COHEN RAYMOND W | Director | Option Exercise | A | 2.06 | 15,000 | 30,900 | 15,000 | |
| Sep 01 2005 | DFIB | CARDIAC SCIENCE IN ... | COHEN RAYMOND W | Chairman and CEO | Option Exercise | D | 2.00 | 100,000 | 200,000 | 0 | |
| Sep 01 2005 | DFIB | CARDIAC SCIENCE IN ... | COHEN RAYMOND W | Chairman and CEO | Option Exercise | D | 2.06 | 1,600,000 | 3,296,000 | 0 | |
| Sep 01 2005 | DFIB | CARDIAC SCIENCE IN ... | COHEN RAYMOND W | Chairman and CEO | Option Exercise | D | 1.75 | 300,000 | 525,000 | 0 | |
| Sep 01 2005 | DFIB | CARDIAC SCIENCE IN ... | COHEN RAYMOND W | Chairman and CEO | Option Exercise | D | 4.00 | 150,000 | 600,000 | 0 | |
| Sep 01 2005 | DFIB | CARDIAC SCIENCE IN ... | COHEN RAYMOND W | Chairman and CEO | Option Exercise | D | 2.00 | 50,000 | 100,000 | 0 | |
| Sep 01 2005 | DFIB | CARDIAC SCIENCE IN ... | COHEN RAYMOND W | Chairman and CEO | Option Exercise | D | 3.99 | 350,000 | 1,396,500 | 0 | |
| Sep 01 2005 | DFIB | CARDIAC SCIENCE IN ... | COHEN RAYMOND W | Chairman and CEO | Sell | D | 0.00 | 128,253 | 0 | 0 | 128.3 K to 0 (-100.00 %) |
| Nov 12 2004 | DFIB | CARDIAC SCIENCE IN ... | COHEN RAYMOND W | CEO | Sell | D | 2.12 | 277,682 | 588,686 | 128,253 | 405.9 K to 128.3 K (-68.41 %) |
Page: 1